Intention-to-treat analysis keeps all trial data, showing true drug effects, even with dropouts. It contrasts with per-protocol analysis, where dropout data is excluded, possibly skewing results.
Per-protocol analysis excludes noncompliant clinical trial participants' data. Mixing per-protocol with other analyses gives a clearer intervention picture. Regulators typically reject sole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback